Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.
Press releases published on September 4, 2025
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
GlobeNewswire
·
September 4, 2025
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance of Myriad’s …
MD Logic Health and Dr. Roxanne Carfora Launch Advanced Cholesterol Support: A Doctor-Created Formula for Heart and Metabolic Wellness
GlobeNewswire
·
September 4, 2025
Miami, Florida , Sept. 04, 2025 (GLOBE NEWSWIRE) -- MD Logic Health®, a trusted leader in science-backed wellness solutions, has partnered with Dr. Roxanne Carfora, D.O., P.C., a Board Certified Anti-Aging and Regenerative Medicine Specialist, to launch …
Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders
GlobeNewswire
·
September 4, 2025
FORT MILL, S.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that September …
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
GlobeNewswire
·
September 4, 2025
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
GlobeNewswire
·
September 4, 2025
HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
GlobeNewswire
·
September 4, 2025
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire
·
September 4, 2025
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Indaptus Therapeutics Provides Clinical Update
GlobeNewswire
·
September 4, 2025
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
GlobeNewswire
·
September 4, 2025
The risk adjusted Net Present Value (rNPV) for TVGN 930 is estimated to exceed ~$250 million in the US alone. Covering five rare disease eligible indications, the accessible market in the US could be as high as 40,000 patients. Focused on improved …
ProductLife Group Memperluas Layanan untuk Keahlian Lokal & Dukungan Klien yang Lebih Baik di Jepang
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangga mengumumkan pembukaan kantor barunya di Jepang, menguatkan komitmennya untuk memenuhi kebutuhan klien dan tuntutan pasar yang terus berkembang. Ekspansi ini meningkatkan …
ProductLife Group, 일본에 진출하며 현지 전문성 강화 및 고객 지원 확대
GlobeNewswire
·
September 4, 2025
파리, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG)이 일본에 신규 사무소를 개소하게 되었다고 발표했다. 이번 확장은 변화하는 고객의 니즈와 시장 수요에 부응하겠다는 PLG의 의지를 강화하는 한편, 역량을 확대하고 지역 및 글로벌 네트워크를 강화하며, 추가 시장과 서비스 지원을 위한 원활한 협업을 가능하게 한다는 취지로 평가된다. 생명과학 기업들이 전 세계적 전문성과 현지 인재를 점점 더 필요로 …
ProductLife Group Mengembangkan Operasi untuk Menyampaikan Kepakaran Setempat dan Sokongan Klien yang Dipertingkatkan di Jepun
GlobeNewswire
·
September 4, 2025
PARIS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) dengan bangganya mengumumkan pembukaan pejabat terbaharu di Jepun, sekali gus memperkukuh komitmennya untuk memenuhi keperluan klien yang semakin berkembang serta tuntutan pasaran yang …
ProductLife Group…
GlobeNewswire
·
September 4, 2025
ปารีส, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ProductLife Group (PLG) ภูมิใจที่จะประกาศการเปิดสำนักงานใหม่ล่าสุดในประเทศญี่ปุ่น เพื่อเสริมสร้างความมุ่งมั่นในการตอบสนองความต้องการของลูกค้าที่เปลี่ยนแปลงและความต้องการของตลาด การขยายตัวนี้ช่วยเพิ่มขีดความสามารถ …
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
GlobeNewswire
·
September 4, 2025
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ …
Avania Strengthens Leadership Team with Appointment of Four New Executives
GlobeNewswire
·
September 4, 2025
BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership appointments of four distinguished executives. As the MedTech …
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
GlobeNewswire
·
September 4, 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today …
Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
GlobeNewswire
·
September 4, 2025
New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal …
Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform
GlobeNewswire
·
September 4, 2025
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth …